Matinas BioPharma Holdings, Inc. (MTNB)
USD 0.59
(-0.45%)
USD 0.59
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.27 Million | -19.15 Million | -15.22 Million | -17.36 Million | -14.09 Million | -10.32 Million |
| Net Income | -22.94 Million | -20.99 Million | -23.28 Million | -22.44 Million | -17.37 Million | -14.08 Million |
| Depreciation & Amortization | 941 Thousand | 898 Thousand | 781.49 Thousand | 774.58 Thousand | 780.81 Thousand | 218.3 Thousand |
| Deferred income taxes | 103 Thousand | - | 2207.00 | 8485.00 | 6417.00 | -506.92 Thousand |
| Stock-based compensation | 4.94 Million | 5.22 Million | 4.29 Million | 4.56 Million | 2.98 Million | 3.83 Million |
| Change in working capital | 1.66 Million | -4.78 Million | 1.53 Million | -508.68 Thousand | -492.06 Thousand | 160.23 Thousand |
| Other non-cash items | 5000.00 | 504 Thousand | 1.45 Million | 239.83 Thousand | 140.00 | 57.15 Thousand |
| Investing Cash Flow | 13.24 Million | 4.87 Million | 16.77 Million | -40.66 Million | -6.01 Million | -535.91 Thousand |
| Investments in PPE | -218 Thousand | -892 Thousand | -260.38 Thousand | -5749.00 | -405.6 Thousand | -535.91 Thousand |
| Acquisitions | - | -5.76 Million | -17.03 Million | 8.48 Million | - | - |
| Investment purchases | - | -9.48 Million | -23.19 Million | -72.1 Million | -5.6 Million | - |
| Sales/Maturities of investments | 13.46 Million | 15.25 Million | 40.22 Million | 31.44 Million | - | - |
| Other Investing Activities | 13.46 Million | 5.76 Million | 17.03 Million | -8.48 Million | -5.6 Million | -535.91 Million |
| Financing Cash Flow | -7000.00 | 79 Thousand | 6.96 Million | 48.04 Million | 29.85 Million | 15.86 Million |
| Debt repayment | -7000.00 | -20 Thousand | -30 Thousand | -54.67 Thousand | -281.55 Thousand | -59.18 Thousand |
| Dividends payments | - | - | -843.6 Million | -682.8 Million | -2.23 Billion | -587.14 Million |
| Common Stock Repurchased | - | - | - | - | 2.23 Billion | - |
| Common Stock Issuance | - | 99 Thousand | 6.99 Million | 48.1 Million | 30.1 Million | 7.05 Million |
| Other Financing Activities | -7000.00 | 99 Thousand | 6.99 Million | 48.1 Million | 30.17 Thousand | 15.92 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -103 Thousand | -321 Thousand | 588.32 Thousand | -329.36 Thousand | 383.65 Thousand | -287.21 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.77 Million | -4.46 Million | 945.12 Thousand | -179.31 Thousand | -875.72 Thousand | 447.45 Thousand |
| Cash at beginning of period | 6.88 Million | 21.28 Million | 12.76 Million | 22.75 Million | 13 Million | 7.99 Million |
| Cash at end of period | 4.83 Million | 7.08 Million | 21.27 Million | 12.76 Million | 22.75 Million | 13 Million |
| Capital Expenditure | -218 Thousand | -892 Thousand | -260.38 Thousand | -5749.00 | -405.6 Thousand | -535.91 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.04 Million | -14.2 Million | 8.51 Million | -9.98 Million | 9.74 Million | 5 Million |
| Free Cash Flow | -15.49 Million | -20.04 Million | -15.48 Million | -17.37 Million | -14.49 Million | -10.85 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.71 Million | -5.82 Million | -22.94 Million | -5.31 Million | -6.05 Million | -6.06 Million |
| Depreciation & Amortization | 241 Thousand | 240 Thousand | 941 Thousand | 240 Thousand | 238 Thousand | 234 Thousand |
| Deferred income taxes | - | - | 103 Thousand | -2.07 Million | - | - |
| Stock-based compensation | 991 Thousand | 995 Thousand | 4.94 Million | 1.27 Million | 1.19 Million | 1.2 Million |
| Change in working capital | 1.41 Million | -1.19 Million | 1.66 Million | -795 Thousand | 185 Thousand | 2.39 Million |
| Other non-cash items | 1.67 Million | 1.53 Million | 5000.00 | 2.09 Million | 17 Thousand | 29 Thousand |
| Investing Cash Flow | -2.93 Million | 2 Million | 13.24 Million | 2.96 Million | 1.08 Million | 6.19 Million |
| Investments in PPE | - | - | -218 Thousand | - | -16 Thousand | -202 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.93 Million | - | - | - | - | - |
| Sales/Maturities of investments | 5 Million | 2 Million | 13.46 Million | 2.96 Million | 1.1 Million | 6.4 Million |
| Other Investing Activities | -2.93 Million | 2 Million | 13.46 Million | 2.96 Million | 1.1 Million | 6.4 Million |
| Financing Cash Flow | 9.18 Million | 53 Thousand | -7000.00 | -1000.00 | -1000.00 | -1000.00 |
| Debt repayment | -1000.00 | -1000.00 | -7000.00 | -1000.00 | -1000.00 | -1000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.19 Million | 54 Thousand | - | - | - | - |
| Other Financing Activities | 9.19 Million | 54 Thousand | -7000.00 | 5000.00 | -1000.00 | -1000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -235 Thousand | -41 Thousand | -103 Thousand | -320 Thousand | 230 Thousand | 89 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.65 Million | -1.15 Million | 1.77 Million | -475 Thousand | -45 Thousand | 2.3 Million |
| Cash at beginning of period | 1.12 Million | 4.83 Million | 6.88 Million | 6.45 Million | 9.99 Million | 5.98 Million |
| Cash at end of period | 4.26 Million | 1.12 Million | 4.83 Million | 4.83 Million | 6.65 Million | 9.99 Million |
| Capital Expenditure | - | - | -218 Thousand | - | -16 Thousand | -202 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.14 Million | -3.71 Million | -2.04 Million | -1.62 Million | -3.33 Million | 4 Million |
| Free Cash Flow | -3.1 Million | -5.76 Million | -15.49 Million | -4.57 Million | -4.43 Million | -2.39 Million |
BANKBARODA
DCO
2338
JXMNF
002987
002766